{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T02:54:28Z","timestamp":1764557668974,"version":"3.40.5"},"reference-count":34,"publisher":"Informa UK Limited","issue":"1","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Cardiovascular Therapy"],"published-print":{"date-parts":[[2023,1,2]]},"DOI":"10.1080\/14779072.2023.2159811","type":"journal-article","created":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T06:00:35Z","timestamp":1671170435000},"page":"5-13","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":6,"title":["An evaluation of mavacamten for the treatment of symptomatic obstructive hypertrophic cardiomyopathy in adults"],"prefix":"10.1080","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0086-9289","authenticated-orcid":false,"given":"Tiffany","family":"Dong","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Nissen","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Ospina","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milind Y","family":"Desai","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,12,22]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.7326\/M18-3016"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1710575"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jew313"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.644682"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2010.04.026"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2016.0252"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.08.045"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.64.3.437"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X1201160126125403"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu284"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1007\/s40256-022-00532-x"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1080\/00498254.2018.1495856"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M117.776815"},{"key":"cit0014","unstructured":"Administration FD. Approved drug proucts: CAMZYOS (mavacamten) capsules for oral use [Webpage]. 2022. [cited 2022 Oct 15]. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/214998s000lbl.pdf."},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3456"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009627"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0168407"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31792-X"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00763-7"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(21)01891-X"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/9417908"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.04.048"},{"key":"cit0023","first-page":"e014986","author":"Cremer PC","year":"2022","journal-title":"Cir Cardiovasc Imaging"},{"key":"cit0024","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.062534"},{"volume-title":"FDA approves new drug to improve heart function in adults with rare heart condition","year":"2022","key":"cit0025"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2021.05.007"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2021.07.065"},{"key":"cit0028","unstructured":"PIONEER-LTE Study Methods. NCT03496168. ClinicalTrials.gov. [cited 2022 Oct 18]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03496168?term=pioneer-ole&draw=2&rank=1."},{"key":"cit0029","unstructured":"MAVA-LTE Study Methods. NCT03723655. ClinicalTrials. gov. [updated August 2022; cited 2022 Oct 17]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03723655?term=MAVA-LTE&draw=2&rank=1."},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.064"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2022.03.345"},{"key":"cit0032","unstructured":"A study of mavacamten in participants with HFpEF and elevation of NT-proBNP with or without elevation of cTnT (EMBARK-HFpEF). NCT04766892. Clinicaltrials.gov [cited 2022 Oct 15]. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04766892."},{"issue":"3","key":"cit0033","first-page":"369","volume":"28","author":"Beinfeld M","year":"2022","journal-title":"J Manag Care Spec Pharm"},{"key":"cit0034","unstructured":"REDWOOD-HCM Study Methods. NCT04219826. Clinical Trials.gov. [cited 2022 Oct 15]. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04219826?term=REDWOOD-HCM&draw=2&rank=1."}],"container-title":["Expert Review of Cardiovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14779072.2023.2159811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T11:28:32Z","timestamp":1675078112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14779072.2023.2159811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,22]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,2]]}},"alternative-id":["10.1080\/14779072.2023.2159811"],"URL":"https:\/\/doi.org\/10.1080\/14779072.2023.2159811","relation":{},"ISSN":["1477-9072","1744-8344"],"issn-type":[{"type":"print","value":"1477-9072"},{"type":"electronic","value":"1744-8344"}],"subject":[],"published":{"date-parts":[[2022,12,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierk20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierk20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-11-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-12-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}